Epstein Secrets

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

THE SPECIMEN WILL BE MAINTAINED IN STORAGE IN CASE ADDITIONAL TESTING IS NEEDED. PLEASE CALL THE CLIENT SERVICE DEPARTMENT FOR FURTHER ASSISTANCE. PROLACTIN 3.9 TESTOSTERONE, TOTAL MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 150 L In hypogonadal males, Testosterone, Total, LC/MS/MS, i

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

d that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.0 2.0-18.0 ng/m1, MI TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 185 L 250-827 ng/dL Net with clinic

ith diabetes plus I major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/c1L) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to MIA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

THE SPECIMEN WILL BE MAINTAINED IN STORAGE IN CASE ADDITIONAL TESTING IS NEEDED. PLEASE CALL THE CLIENT SERVICE DEPARTMENT FOR FURTHER ASSISTANCE. PROLACTIN 3.9 TESTOSTERONE, TOTAL MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 150 L In hypogonadal males, Testosterone, Total, LC/MS/MS, i

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

d that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.0 2.0-18.0 ng/m1, MI TESTOSTERONE, TOTAL MI MALES (ADULT), IA TESTOSTERONE, TOTAL, MALES (ADULT), IA 185 L 250-827 ng/dL Net with clinic